Exploratory Biomarker Analysis of Neoadjuvant Chemoimmunotherapy Followed by Pulmonary Resection in Stage II-III Non-Small Cell Lung Cancer

RecruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

August 7, 2024

Primary Completion Date

February 28, 2026

Study Completion Date

June 30, 2029

Conditions

Clinical Stage II to III Non-Small Cell Lung Cancer

Trial Locations (1)

RECRUITING

Department of Thoracic and Cardiovascular Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul

All Listed Sponsors

lead

Yonsei University

OTHER